Target Identification
Identifies targets using multi-source data, scoring novelty, druggability, genomics.
What You'll Get
- Prioritized targets with AI scoring
- Reduced risk via AI insights

Explore AI-driven offerings across discovery and clinical development
Explore AI-driven services across discovery and clinical development.
Identifies targets using multi-source data, scoring novelty, druggability, genomics.
What You'll Get
Discover clinically actionable biomarkers using AI-driven multi-omics for asset insights.
What You'll Get
AI-driven de-novo design generates optimized novel molecules.
What You'll Get
Design high-performing antibody-drug conjugates using AI modeling.
What You'll Get
Identifies new indications using AI-driven network analysis.
What You'll Get
AI engine identifies inhalation-ready candidates using ADME, biology, & safety.
What You'll Get
Predicts drug synergy and optimizes combinations to improve efficacy.
What You'll Get
AI-driven antibody optimization generates high-affinity binders.
What You'll Get
Predicts absorption, distribution, metabolism, excretion, and toxicity to boost drug discovery.
What You'll Get
Optimize trials, predict outcomes, and improve success rates
AI predicts clinical trial success probability using drug, disease, and design data.
What You'll Get
AI predicts success of hypothetical trials using simulated design and historical data.
What You'll Get
AI optimizes trial protocols using data-driven insights to improve design and success rates.
What You'll Get
AI-engine optimizes trial planning by scoring sites and mapping KOLs.
What You'll Get
Not sure which service fits your needs? Our experts can guide you.